Trial Profile
Efficacy of Rituximab versus Cyclophosphamide induction therapy in the treatment of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2016
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide
- Indications Churg-Strauss syndrome
- Focus Therapeutic Use
- 17 Aug 2016 New trial record